The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

Alvin Lee Day, Kevin L. Winthrop, Jeffrey R. Curtis

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

Original languageEnglish (US)
Pages (from-to)695-703
Number of pages9
JournalCleveland Clinic journal of medicine
Volume87
Issue number11
DOIs
StatePublished - Nov 2020

Keywords

  • Influenza vaccine should be given yearly to all patients on DMARDs
  • with modification to either the timing of DMARD or vaccine administration for patients receiving methotrexate or rituximab

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults'. Together they form a unique fingerprint.

Cite this